Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Mar 08, 2018 10:31am

160 Views

Post# 27682704

RE:RE:Credit Suisse raised Taimed PT to 425

jfm1330 wrote:

SPCEO1 wrote: I wish they would pick up coverage of TH!

WOW!!! This is a bold target given the fact Taimed valuation is actually four time higher than Thera. So the new target would make Taimed worth seven time the actual valuation of Thera. So a Thera SP of 65$ CAN.

Canadian analysts are being made to look silly.

Theratechnologies really needs to be investigating a Nasdaq listing.

bfw

Bullboard Posts

Soma Gold poised to extend profitable track record